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Abstract
Background: Filum terminale (FT) is a structure that is intimately associated with conus medullaris, the most caudal part of
the spinal cord. It is well documented that certain regions of the adult human central nervous system contains
undifferentiated, progenitor cells or multipotent precursors. The primary objective of this study was to describe the
distribution and progenitor features of this cell population in humans, and to confirm their ability to differentiate within the
neuroectodermal lineage.
Methodology/Principal Findings: We demonstrate that neural stem/progenitor cells are present in FT obtained from
patients treated for tethered cord. When human or rat FT-derived cells were cultured in defined medium, they proliferated
and formed neurospheres in 13 out of 21 individuals. Cells expressing Sox2 and Musashi-1 were found to outline the central
canal, and also to be distributed in islets throughout the whole FT. Following plating, the cells developed antigen profiles
characteristic of astrocytes (GFAP) and neurons (b-III-tubulin). Addition of PDGF-BB directed the cells towards a neuronal
fate. Moreover, the cells obtained from young donors shows higher capacity for proliferation and are easier to expand than
cells derived from older donors.
Conclusion/Significance: The identification of bona fide neural progenitor cells in FT suggests a possible role for progenitor
cells in this extension of conus medullaris and may provide an additional source of such cells for possible therapeutic
purposes. Filum terminale, human, progenitor cells, neuron, astrocytes, spinal cord.
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Introduction
Filum terminale (FT) is a structure that during development and
is attached to the first segment of the coccyx. Under normal
conditions the FT is thin and does not prevent free movements of
the spinal cord. In few individuals this connection is maintained
which then effects growth and posture, induces pain and leads to
neurological symptoms of the condition teathered cord. The normal
human FT is mainly a fibrous band, composed of two segments,one
intradural and one extradural. FT contains an extension of the
central canal which is lined with ciliated ependymal cells
[1,2,3,4,5,6,7]. Throughout the FT this canal can disappear and
reappear in distal portions. To avoid neurological deficit, FT is
divided during surgery in patients that suffer from tethered cord
[4,8]. This surgery can be undertaken with a small resection of FT
without development of neurological deficits. With ethical permis-
sion we utilized these surgical procedures to harvest tissue from FT.
Early reports suggested that FT could contain neural tissue [9,10].
Choi et al. demonstrated that FT contains an abundance of glial
cells, ependymal cells and what has been described as degenerated
neuronal elements [1]. It was recently shown that cells from FT
contain progenitor–like cells, which could form neurospheres. These
neurosphere-derived cells could differentiate into neurons, astrocytes
and oligodendrocytes [11]. Since the original published article on in
vitro isolation of neural stem cells in the adult central nervous system
(CNS), several groups have shown that stem/progenitor cells
cultured from the ventricular wall of adult humans may differentiate
into neurons [12]. These cells can develop mature biological and
electrophysiological features, including synaptic communication
[13,14]. These findings opened the possibility to replace lost neurons
or glia by transplantation of cultured neural progenitor cells
harvested and multiplied from the ventricular wall.
In this study we investigate the occurrence and distribution of
neural stem/progenitor cells in FT. We explored the expression of
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27393stem cell markers; reveal the distribution of progenitor cells and
their capacity for expansion and response to growth factor
stimulation. We applied protocols previously used for character-
ization of progenitors [12] already known to be present in the
subventricular zone (SVZ) and in the dentate gyrus of the
hippocampal formation [15,16,17,18,19]. Here we describe the
localization and morphology of cells expressing progenitor cell
characteristics and provide further evidence for the existence of a
progenitor cell pool in the human FT.
Results
The distribution of progenitor cells in the filum terminale
In order to identify the cellular elements and localize progenitor
cells in human FT, immunohistochemistry was performed using
the progenitor cell markers Sox2 and Musashi-1 on sagittal and /
or coronal sections. Sox2-immunoreative cells were abundant in
the FT (Fig. 1). Subependymal bands of 10–20 cells appeared in
streaks and small clusters, we also found very large clusters of more
than 500 cells/section (Fig.1 C, D and E). Sox-2 labelled cells were
found in the ependymal cell layers surrounding the central canal.
(Fig. 1 F, G). There was no apparent rostrocaudal gradient of
Sox2-immunoreactive cell density.
Musashi-1 immunoreactivity was also detected in ependymal
cells surrounding the central canal as well as in the subependymal
compartment where the cells were found in organized layers but
also scattered in larger clusters at the surface of FT (Fig. 2A).
Musashi-immunoreactive cells could also be found in smaller islets
at a distance from the central canal (Fig. 2B). Double
immunolabelling revealed that Musashi-1-positive cells were also
Sox2-positive (Fig. 2C). A very strong GFAP immunoreactivity
was observed in the progenitor cells, with a weaker GFAP
immunoreactivity in the surrounding tissue (Fig. 2D, E). Cells
expressing strong immunolabelling for Sox2 were also GFAP
positive (Fig. 2E, F). As determined from b-III tubulin staining, the
axonal density of the FT was very low, and neuronal cell bodies
were rarely found (NeuN, data not shown).
Expansion and differentiation of progenitor cells from
filum terminale
We next extended our study to learn whether we could isolate
and expand neural stem/progenitor cells from FT. Specimens
from patients of different ages (1–60 years) were successfully
isolated and similar to the cells isolated from other human brain
tissues, SVZ tissue, single cells were able to form neurosphere in
13 out of 21 patients (62%, Table 1). FT derived neurospheres
were frequently detected from young patients and had an
excellent growth capacity and could be passaged for up to 15–
30 passages (n=6). Moreover, these progenitor cells shows higher
capacity for proliferation and is easier to expand than cells
derived from older donors. However, it was also possible to
propagate cells from older donors but with lower growth rate
compared to the younger donors (Table 1, Fig.3). These spheres
resembled spheres obtained from the previously described
regenerative zones of the CNS (Fig. 4A). Proliferation of the
progenitor cells was confirmed by BrdU incorporation and Sox2
staining (insert Fig. 4A). To test if FT derived neurospheres have
self-renewal capacity, we isolated single cells from the neuro-
spheres and cultured them at a density of 60 cells per ml. Single
isolated cells gave rise to secondary neurospheres, demonstrating
that some cells possess self-renewal capacity. A clonal expansion
study showed that 60 primary culture cells was the minimal
number needed to form one neurosphere which indicate a
relatively strong self-renewal capacity. The expansion rate and
yield of cells was highly variable between individuals. In spite of
this, the cells could be cultured for up to 29 passages. In cells at
early stages of differentiation nestin immunolabeling was present
(Fig. 4B).
Eleven days post-differentiation, we observed GFAP-positive
cells with morphological and phenotypic characteristics of
astroglia (Fig. 4C). Under regular growth conditions FT cultures
5% of the cells expressed b-III-tubulin upon differentiation
(Fig. 4D) In a subset of patients the b-III-tubulin expression was
validated for each expansion of the cells and was maintained up to
the maximum of 29 expansions (Table 2). Cells of the
Figure 1. Distribution of Sox2-positive cells within filum
terminale. (A) Longitudinal section represents an overview of the
distribution and localization of the neuronal progenitor cells in human
FT revealed by Sox2-positive cells (red) and the nuclear staining DAPI
(blue). (B–E) Represent higher magnifications demonstrating Sox2-
positive cells localized subependymally and outlining the central canal.
(F and G) represent coronal adjacent sections, (F) stained with
florescence staining. The central canal is indicated with an asterix (G)
Coronar section stained with Haematoxylin–eosin staining. Arrows (in F
and G) indicates corresponding areas. A–F; confocal, G; light
microscopy. Scale bars: A=100 mm; B=50 mm; C2G=40mm.
doi:10.1371/journal.pone.0027393.g001
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Concomitant with differentiation, the number of nestin-positive
cells declined, as expected. PDGF-BB was added to the
differentiation medium since it acts as a mitogen in the early
phases of stem cell differentiation and promotes survival and
proliferation of immature neurons [20,21,22]. Administration of
PDGF-BB resulted in a significant (ten fold) increase in the amount
of b-III-tubulin positive cells, in comparison to control cultures
(Fig. 4E, F).
Comparisons to rat filum terminale
Longitudinal sections from human and rat FT confirmed the
presence of a central canal structure with a border of ependymal
cells within the vascular fibrous and fatty tissue and collagen bands
that constitutes the FT. In the rat the central canal is large and well
defined whereas in the human, it is more of a scattered system of
tubular structures lined by ependymal-type cells (Fig. 5A). These
structures were considered to represent embryonic ependymal
remnants in the FT. Similar central canal structures with
ependymal cells were found at the level of conus medullaris of rat
(Fig. 5B) and was prominent at more caudal levels (Fig. 5C and D).
Also in the rat FT, the ependymal cells expressed nestin, a marker
Figure 2. Presence of additional progenitor markers in the filum terminale. (A) Longitudinal section and (B) coronal section shows clusters
of Musashi-positive cells within the FT (red) and nucleus staining DAPI (blue). (A) A large cluster of Musashi-positive cells at the surface of the FT.
Insert represents higher magnification of the boxed area. (B) Small clusters of Musashi-positive cells within the FT. (C–F) Double-immunolabeled
sections from human FT show that Sox2 immunoreactivity (green) was colocalized with Musashi immunoreactivity (red) (C). The Sox2 (red) cells were
also expressing GFAP (green) (D–F). Scale bars: A,D,E,F=40 mm, B,C and insert box=20 mm.
doi:10.1371/journal.pone.0027393.g002
Table 1. Age of donors and the number of neurospheres
formed.
Age group n Spheres No spheres
1–5 8 6 2
6–15 8 4 4
.30 5 3 2
doi:10.1371/journal.pone.0027393.t001
Figure 3. Quantitative determination of cell expansion from
young donors (1–7years) and old donors (42–60years). The
number of obtainable cell passages in young donors was significantly
higher than old donors. *P ,0.05.
doi:10.1371/journal.pone.0027393.g003
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cells were also cultured. We obtained neurospheres from 5 out of 13
cultures (39%). Cells from rat FT were difficult to expand, which
may relate to the small amounts of harvested tissue.
Discussion
The caudal part of the spinal cord in reptiles, mice and avians
are different. Reptiles lack a true FT, whereas in birds, the
equivalent region of FT contains neurons [23]. In contrast, such is
not the case for mouse in which no neural markers are present in
this region [24]. The present morphological study of the human
FT was carried out since this region has been shown to contain
cells with stem cell properties [11]. Here we focused on the
location, distribution and organization of the progenitor cells
within the FT. We found that Sox2 positive cells were abundant in
the ependymal layer and the subependymal area adjacent to the
central canal as well as in the form of islets of Musashi positive
cells. The Musashi family belongs to a conserved group of
neuronal RNA-binding proteins [25]. Sox2 is a transcription
factor which is critical in maintaining pluripotency and self-
renewal. Sox2 and Musashi have been shown to be selectively
expressed in the neuronal progenitor cells [25,26,27,28]. Co-
localization of Musashi and Sox2 was seen in a majority of cells in
the FT. The general morphology of the human FT has previously
been described [1] and our findings are in line with the previous
findings, showing the presence of fibrous tissue, astrocytes and
ependymal cells. We were, however, surprised by finding so many
cells expressing pluripotency markers and that they were present
throughout the length of FT.
The establishment of viable cultures was not always achieved,
this could, in part be explained by the operating technique which
often involves electro-coagulation, and thereby may devitalize the
cells. The yield of cells was highly variable between individuals
which could be explained by the variation in anatomy between
individuals together with the use of electro-coagulation during the
surgical procedure. These patients are operated for tethered cord
syndrome which is a pathological state. The tissue decribed here is
thereby not entirely normal, although tumors are excluded. For
ethical reasons healthy filum is not accessible. This rare procedure
is performed only 10–15 times per year and some material was
discarded due to the finding of a tumor, such as lipoma or
ependymoma which may arise in this region[29,30].
Our findings are interesting from two clinical perspectives; as
source of progenitor cells and from the perspective of tumor
formation, which was not addressed in this study. We confirmed
here that FT contains neural stem/progenitor cells. Since all
humans possess this structure, these cells can potentially be used
for auto-transplantation purposes. Identification of neural stem
cells in humans has opened possibilities for transplantation
strategies to treat neurodegenerative diseases; including supporting
compromised neurons in a damaged spinal cord. Neural stem cells
Figure 4. Human FT cells in culture. (A) Neurosphere after second passage. BrdU-positive (green) and Sox2-positive (red) cells in
neurosphere from human FT (Insert in A). (B) Nestin-positive cells (green) after 28 days with nuclear marker Hoechst (blue). (C) GFAP-positive cells
with astroglial shape (red) and (D) One neuronal (b-III-tubulin) cell as it appears after 11 days of differentiation (blue=DAPI). (E) Expansion of cells
without PDGF-BB. (F) Cells expanded in culture medium exposed to PDGF-BB for 8 days, GFAP (red), b-III tubulin (green) and nuclear marker Hoechst
(blue). Bars: A and B=10 mm, Insert=25 mm, C and D=5 mm and E2F=20mm.
doi:10.1371/journal.pone.0027393.g004
Table 2. The longitudinal expression of b-III-tubulin followed
in a subset of patients.
Age Gender Expansions b-III-tubulin
1F P 1 5 +
2M P 2 0 +
4F P 2 9 +
7M P 1 0 +
42 M P6 +
60 M P5 not done
doi:10.1371/journal.pone.0027393.t002
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damage to the CNS. An alternative structure in the CNS, such as
the FT, would give new possibilities to isolate neural stem/
progenitor cells without damaging the CNS. Our results revealed
that FT derived cells were found to have self-renewal capacity and
the ability to grow in vitro to form numerous neurospheres in a
similar manner as stem/progenitor cells derived from the
subventricular zone (SVZ) [12,14,31]. Interestingly, the self-
renewing properties were maintained also in tissue from adult
donors (.age 30), suggesting that this progenitor pool is
maintained during adulthood. The result showed also that the
progenitor cells detected can reach different cell passage
depending on age. The cells from young patients have larger
growth capacity, higher proliferative ability and easier to expand
than cells derived from older donors. In rat neurosphere
proliferation rate, telomerase activity decreases with age [32], also
in the hippcampus of rat the proliferation of the CA1 cells
decreases with age [33].
After differentiation the cultures were labelled with b-III-tubulin
as a marker for neurons [34,35]. Interestingly, in response to
PDGF-BB stimulation, the number of b-III-tubulin positive cells
increased. It has been shown that PDGF-BB supports neuronal
differentiation of CNS stem cells by acting as a mitogen in the
early phases of stem cell differentiation, promoting survival and
proliferation of immature neurons [20,21,22]. The response to
PDGF-BB indicates that the cells are early progenitors the cell fate
of which can be influenced and directed as is the case for SVZ
progenitor cells. Varghese et al., (2009), transplanted human FT
cells to Sprague Dawley rats in a global ischemia model and found
that the cells developed into GFAP expressing cells, however -as
expected, eliciting a strong immune reaction [11]. The abundance
of progenitor cells, expressing markers of immaturity throughout
the FT may also be of relevance for tumor formation in this
region. We speculate that dedifferention occurring in the
ependymal progenitor clusters could be the origin of the
myxopapillary ependymoma sometimes encountered in the region
[29,36].
In summary, our findings add further evidence for the existence
of cells with neuronal progenitor nature within the FT. We
demonstrate the abundance and distribution of the cells and their
ability to respond to growth factors. We also demonstrate that the
progenitor cells detected from young patients have greater growth
capacity, higher proliferative ability and more easy to expand than
cells derived from older donors. Since the FT can be removed
without functional impairment it may represent an attractive CNS
reservoir of neural stem/progenitor cells.
Materials and Methods
Tissue preparation
I. Human tissue. Patients suffering from tethered cord are
usually treated surgically by dividing and resecting a part of the FT
in the lumbosacral region. This tissue was obtained from young
and adult patients (ages 1–60 yrs) between 2006–2011. All patients
(n=21) underwent MRI scans to exclude tumors and were
screened for the presence of infectious disease. The tissue was
immediately stored in L15 medium (4uC) at the operating theatre
and immediately transported to our laboratory. Part of FT tissue
from patients was fixed in ice-cold 4% PFA (24 h), and
cryoprotected in 17% sucrose before being imbedded in
Cryomount (HistoLab Gothenburg). FT was longitudinally and/
or coronally sectioned. Another part was performed for the cell
culture.
II. Rat tissue. Adult male Sprague-Dawley rats (n=7)
(Scanbur B&K, Sollentuna, Sweden), weight 400–500 g, were
deeply anesthetized using intraperitoneal injection of 0.5 mg/kg
medetomidine (Domitor Vet. 1 mg/ml, OrionPharma) and
75 mg/kg ketamine (Ketalar 50 mg/ml, Pfizer). Animals were
Figure 5. Anatomical comparison between the human and rat filum terminale. (A) Longitudinal section of human FT stained with
haematoxylin-eosin. The human FT mostly consists of astrocytes and ependymal cells (see arrows) (B–D). Transverse sections of rat FT stepwise from
conus (B) and further caudally (C and D) the central canal is prominent in the middle of the rat film. Rounded brown structures in the perperiphery
represent nerve roots. (E and F). Longitudinal sections of the rat FT labelled with a nestin antibody (red) and a nuclear marker DAPI (blue). (F) Higher
magnification of boxed area in (E). Bars: A and E=40 mm, B and C=100 mm, F=5 mm. Asterix= central canal.
doi:10.1371/journal.pone.0027393.g005
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saline followed by cold (4uC) 4% PFA (Apoteket) in PBS. The FT
was removed and post fixed for 1 h in cold (4uC) 4% PFA in PBS
followed by rinse in PBS and cryoprotected for 1 h in 17% sucrose
(w/v) in PBS. FT was cryosectioned in longitudinal and transverse
sections (10 mm thick) using a Leica CM3000 (Leica
Microsystems). Sections were mounted on SuperFrost Plus
microscope slides (Menzel-Gla ¨ser).
Immunohistochemistry
1. Human sections. The sections were washed in PBS for
30 min and then incubated for 60 min in PBS
Containing 1% bovine serum albumin (BSA), 0.3% Triton-X
and 0.1% sodium azide.
Sections were incubated with the following antibodies: rabbit
anti-Sox2 (Millipore, dil. 1:200), rabbit anti-Musashi 1 (Millipore,
dil. 1:200), mouse anti-b-III-tubulin (Millipore, dil. 1:100), mouse
anti-NeuN (Millipore, dil. 1:100), mouse anti-GFAP (Chemicon,
dil. 1:1000), mouse anti-O4 (Chemicon, dil. 1:50) and rabbit anti-
p53 (Santa cruz, dil. 1:400). All sections were incubated with the
primary antibody for 24 h at 4uC, rinsed in PBS and subsequently
incubated with species-specific secondary antibodies conjugated
with Cy3 (goat anti-mouse, donkey anti-mouse, goat ant-rabbit or
donkey anti-rabbit) (Jackson ImmunoResearch) (1:500) and Alexa
488 donkey anti-rabbit (1:500) (Invitrogen). Sections were also
counterstained with the nuclear marker DAPI (Invitrogen, dil.
1:2000) or TO-PRO-3 (Invitrogen, dil.1:10000). Sections were
mounted in Mowiol (Calbiochem). For negative controls the
primary antibody was omitted (data not shown). For the Avidin
Biotin Complex (ABC)-technique sections were incubated with
biotinylated secondary antibodies (Vector Laboratories) (1:200) for
1 h at room temperature, rinsed in PBS and incubated with ABC
(Vectastain ABC Kit) for 1 h. After another step of rinsing in PBS
followed by TRIS-hydrogen chloride buffer (0.1 M, pH 7.45)
immunoreactivity was revealed by incubation in 3, 39-diamino-
benzidine (DAB) by using the DAB Substrate Kit for Peroxidase
(Vector Laboratories) for 2–10 min. Sections were rinsed in TRIS
and dehydrated through a series of rinses with increasing strength
of ethanols to pure xylene and mounted in a non-aqueous DPX-
medium.
2. Rat sections. Cryosections from rat FT were air-dried,
washed in PBS for 30 min and then incubated for 60 min in PBS
containing 1% BSA, 0.3% Triton-X and 0.1% sodium azide to
prevent nonspecific binding. All of the primary antibodies used
were diluted in this solution. Cell cultures were fixed with 4% PFA
in PBS. The cells were blocked in PBS, 0.1% saponin and 5% goat
serum. Preparations were incubated with the primary antibody
mouse anti-Nestin (dil. 1:100, Chemicon) for 24 h at 4u C, rinsed
in PBS and subsequently incubated with species-specific secondary
antibodies diluted in PBS; Alexa 488 donkey anti-mouse 1:500
(Molecular Probes/Invitrogen). Sections were also counterstained
with nuclear markers DAPI (Molecular Probes, Invitrogen). Tissue
was also stained for hematoxylin-eosin. The tissue was mounted in
Mowiol (Calbiochem, VWR International).
Microscopy
For analysis of the different antibodies a combination of a laser
scanning confocal microscope (Leica TCS SPII) (Leica Micro-
systems) and a wide field microscope (Leica DM 400B) (Leica
Microsystems) was used. The confocal immunofluorescence
images were obtained using a 20x (N/A 0.7) and 63x (N/A
1.40) objective. Alexa 488, Cy3 and Cy5 were excited at 488 nm,
543 nm and 633 nm respectively and detected with a 490–
520 nm, 560–630 nm and 640–750 nm band-pass filter respec-
tively. Each optical section (1 mm) was averaged four times; images
were the projection of 25 successive optical sections into one
image. In the fluorescence wide field microscope images were
acquired with a Leica DFC320 (Leica) camera. Images of
neurospheres in cell culture were taken before and after the
second passage by using Panasonic CCTV camera (WV-BP312E)
(Panasonic) and an Olympus Microscope (CK2 ULWCD 0.3)
(Olympus).
Filum terminale culture
Cells were isolated from the tissue according to a protocol
previously described by Johansson et al [12]. Connective tissue was
peeled off and the FT was mechanically dissociated with scalpels
and scissors and placed in a dissociation medium, consisting of
200 U/ml DNAse (Sigma-Aldrich) and 0,025% trypsin (Invitro-
gen) or 10 U/ml papain (Worthington) in a 37uC water bath for
30 min. Tissue was triturated three times every 5 min, and further
incubated. To stop the enzymatic reaction, 10 mg/ml BSA
(Sigma-Aldrich) and 10 mg/ml ovomucoid (Worthington) were
mixed with L15, added and mixed with the dissociation medium.
Cells were collected by centrifugation at 220 g for 5 min. To
further enrich for progenitor cells, 0.9 M sucrose in Hanks’
Balanced Salt Solution (HBSS) (Invitrogen) was added to the tissue
solution followed by centrifugation at 750 g for 10 min and
washing with L15. The cell pellet was resuspended and to allow
single cell cultures in 5 or 10 cm Ø petri dishes in neurosphere
medium, composed of DMEM/F12 (invitrogen), HEPES (Gibco),
B27 supplement (Gibco) and Penicillin-Streptomycin (Invitrogen).
To propagate human FT progenitor cells, the following growth
factors were added; 20 ng/ml recombinant human epidermal
growths factor (EGF, R&D systems) or mouse EGF (BD
Bioscience) and 20 ng/ml recombinant human basic fibroblast
growth factor (bFGF, R&D systems). After the first passage,
10 ng/ml recombinant human leukaemia inhibitory factors
(Chemicon) were added to the medium. The neurospheres were
cultured until they reached a critical size which normally took
seven weeks. Another set of cells was cultured in neurosphere
medium with the addition of 20% BIT 9500 medium. BIT
medium consists of BSA, insulin (SIGMA) and 20 ng/ml
transferrin (Stem Cell Technologies). Platelet-derived growth
factor- BB (PDGF-BB) (R&D systems) was added at 30 ng/ml.
Cells were incubated for eight days and the medium was changed
three times. Cells cultured with BIT 9500 medium were
differentiated on gelatine-coated plates (Sigma-Aldrich). In order
to exclude contamination of the data by tumor forming cells, all
tissue preparations were screened for the presence of the P53 gene.
Cell cultures were fixed with 4% PFA and blocked in PBS, 0.1%
saponin and 5% goat serum. Preparations were incubated with the
primary antibodies; rabbit-anti-GFAP 1:1000 (DAKO), mouse
anti-h-Nestin 1:1000(R&D Systems), mouse anti-Tubulin b-III
1:50 (Chemicon) for 24 h at 4u C, rinsed in PBS and subsequently
incubated with species-specific secondary antibodies diluted in
PBS; Alexa 488 donkey anti-mouse 1:500 (Molecular Probes/
Invitrogen), Cy3 donkey anti-rabbit 1:1000 (Jackson Immunor-
esearch). Cells were counterstained with nuclear markers Hoechst
(Molecular Probes, Invitrogen). The tissue was mounted in Mowiol
(Calbiochem, VWR International).
In order to evaluate the proliferation capacity of FT another set
of culture was performed as previously described. After passage the
neurosphers were pulsed with 5-bromo-2’-deoxyuridine (BrdU,
Sigma) for 48 h in the presence of EGF and bFGF. The spheres
were placed on coated glasses and before fixating them with PFA
4%. The glasses were stained for BrdU, Sox2 and DAPI (data not
shown). BrdU incorporation was detected using rat anti-BrdU
Progenitor Cells in the Human Filum Terminale
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anti-rat IgG Alexa 488 (1:100, Invitrogen).
Statistical analysis was performed by using unpaired two-tailed
Students t2test (GraphPad PrismH 5.0, GraphPad Software Inc.,
La Jolla, CA, USA). Data are presented as mean 6 SD, and *P
,0.05 was defined as statistical significance.
Ethical aspects
This study was carried out in accordance with the Helsinki
declaration. The experimental procedures were approved by the
Stockholm county ethical committee for human research (app no
138–31). It is emphasized that the human tissue used for these
experiments should otherwise have been discarded. Tissue from the
patients was only obtained from Karolinska University Hospital,
and under informed consent by the patient or parent in accordance
with the approval by Stockholm county ethical committee at
Karolinska University Hospital. Information was given verbally and
in writing. A verbal consent, as stated in the patients records was in
this cases in agreement with the law of biobanking. The animal
experiments were approved by the Stockholm county ethical
committee (approval no 45–07) Animal care was in accordance to
the recommendations at Karolinska Institutet.
In summary, our findings add further evidence for the
existence of cells with neuronal progenitor nature within the
FT. We demonstrate the abundance and distribution of the cells
and their ability to respond to growth factors. We also
demonstrate that the progenitor cells detected from young
patients have greater growth capacity, higher proliferative ability
and more easy to expand than cells derived from older donors.
Since the FT can be removed without functional impairment it
may represent an attractive CNS reservoir of neural stem/
progenitor cells.
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